Phase I trial and correlative laboratory studies of bryostatin 1 (NSC 339555) and high-dose 1-B-D-arabinofuranosylcytosine in patients with refractory acute leukemia

Louise H. Cragg, Michael Andreeff, Eric Feldman, John Roberts, Anthony Murgo, Mary Winning, Mary Beth Tombes, Gail Roboz, Lora Kramer, Steven Grant

Research output: Contribution to journal › Article › peer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial and correlative laboratory studies of bryostatin 1 (NSC 339555) and high-dose 1-B-D-arabinofuranosylcytosine in patients with refractory acute leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences